GLP-1 Meds: What are they and should employers cover them?

  • Home
  • /
  • Blog
  • /
  • GLP-1 Meds: What are they and should employers cover them?



Over the last two years, GLP-1 medications have emerged as a promising solution for weight loss, especially for individuals struggling with obesity. As we approach 2024, one question that arises is: will employers begin covering GLP-1 weight loss medication in their health plans? In this post, we will delve into the current landscape of healthcare coverage for weight loss medications, the potential impact of including GLP-1 medications in employer-sponsored health plans, and projections for the future.


What is GLP-1?

Glucagon-like peptide-1 (GLP-1) is a hormone that plays a critical role in regulating appetite and food intake. GLP-1 medications work by mimicking the action of this hormone, thereby aiding in weight loss.


How GLP-1 Aids in Weight Loss

These medications slow down digestion, reduce appetite, and improve blood sugar control, making them an effective tool for weight management, particularly for people with type 2 diabetes. Obesity has become a global epidemic, with millions of individuals affected worldwide. In the United States alone, obesity rates have been steadily climbing, leading to a host of health issues like heart disease, diabetes, and stroke.


Many health plans currently provide limited coverage for weight loss medications, often categorizing them as “lifestyle drugs.” This perspective has historically hindered access to effective treatment options for obesity. Employers offer a variety of health plans, from traditional PPOs to more modern HSAs. The decision to include specific medications like GLP-1 for weight loss often depends on factors like cost, perceived value, and employee demand.


The inclusion of GLP-1 medications in health plans is not just a health decision but also a financial one. While these drugs can be expensive, they potentially offer long-term savings by reducing obesity-related health complications. Some progressive companies have already started to include weight loss medications in their health plans, witnessing improvements in employee health and, subsequently, productivity.


The legal landscape around health benefits is complex. With GLP-1 medications gaining FDA approval for weight loss, employers must navigate these regulations carefully when considering coverage. There is a growing demand among employees for comprehensive health benefits that include weight management solutions. This demand aligns with the rising trend of holistic wellness programs in the workplace. Healthcare experts and analysts provide insights into the evolving landscape of employer health benefits. There is a cautious optimism that more employers will start covering GLP-1 medications in 2024.


Insurance companies play a pivotal role in determining the coverage of medications. Their policies on GLP-1 medications will significantly influence employers’ decisions. Despite the benefits, several barriers may impede the inclusion of GLP-1 medications in health plans, including high costs and concerns about long-term efficacy and safety.


The feasibility of including GLP-1 medications in health plans varies between small and large businesses, each facing unique challenges and opportunities. Employers must educate their workforce about the benefits and limitations of GLP-1 medications and provide necessary support structures for those opting for this treatment.


As 2024 approaches, the potential for employers to cover GLP-1 weight loss medication remains a topic of significant interest and debate. Staying informed about these developments is crucial for both employers and employees.


Log in or Register to save this content for later.